Germline mutations of APC in patients with Turcot syndrome (colon cancer and medulloblastoma), was well as somatic mutations of APC, beta-catenin, and Axin in sporadic medulloblastomas (MBs) have shown the importance of WNT signaling in the pathogenesis of MB. A subset of children with MB have germline mutations of SUFU, a known inhibitor of Hedgehog signal transduction. A recent report suggested that murine Sufu can bind beta-catenin, export it from the nucleus, and thereby repress beta-catenin/T-cell factor (Tcf)-mediated transcription. We show that an MB-derived mutant of SUFU has lost the ability to decrease nuclear levels of beta-catenin, and cannot inhibit beta-catenin/Tcf-mediated transcription as compared to wild type SUFU. Our resu...
Suppressor of Fused (SuFu), a tumour suppressor mutated in medulloblastoma, is a central player of H...
The TCF4 gene encodes for the basic helix–loop–helix transcription factor 4 (TCF4), which plays an i...
Current treatment for medulloblastoma is successful in more than half of all cases but results in su...
The sonic hedgehog (SHH) signaling pathway directs the embryonic development of diverse organisms an...
Medulloblastoma (MB) is the most common malignant childhood brain tumor. Approximately 30% of MBs ar...
Hedgehog (Hh) signaling is essential for embryonic development and adult homeostasis. Aberrant path...
SCF (Skp1-Cul1-F-box protein) ubiquitin ligases direct cell survival decisions by controlling protei...
Medulloblastomas represent the most frequent malignant brain tumour in children, and are thought to ...
Suppressor of Fused (SuFu), a tumour suppressor mutated in medulloblastoma, is a central player of H...
Cerebellar granule cell (GC) development relies on precise regulation of the Sonic Hedgehog (Shh) si...
Suppressor of Fused (SuFu), a tumour suppressor mutated in medulloblastoma, is a central player of H...
Medulloblastomas (MB) are the most common pediatric nervous system malignancy. Known mutations accou...
The Hedgehog pathway is a potent regulator of cellular growth and plays a central role in the develo...
Gene mutations impairing the functions of the WNT signaling transduction pathway have been found in ...
The TCF4 gene encodes for the basic helix-loop-helix transcription factor 4 (TCF4), which plays an i...
Suppressor of Fused (SuFu), a tumour suppressor mutated in medulloblastoma, is a central player of H...
The TCF4 gene encodes for the basic helix–loop–helix transcription factor 4 (TCF4), which plays an i...
Current treatment for medulloblastoma is successful in more than half of all cases but results in su...
The sonic hedgehog (SHH) signaling pathway directs the embryonic development of diverse organisms an...
Medulloblastoma (MB) is the most common malignant childhood brain tumor. Approximately 30% of MBs ar...
Hedgehog (Hh) signaling is essential for embryonic development and adult homeostasis. Aberrant path...
SCF (Skp1-Cul1-F-box protein) ubiquitin ligases direct cell survival decisions by controlling protei...
Medulloblastomas represent the most frequent malignant brain tumour in children, and are thought to ...
Suppressor of Fused (SuFu), a tumour suppressor mutated in medulloblastoma, is a central player of H...
Cerebellar granule cell (GC) development relies on precise regulation of the Sonic Hedgehog (Shh) si...
Suppressor of Fused (SuFu), a tumour suppressor mutated in medulloblastoma, is a central player of H...
Medulloblastomas (MB) are the most common pediatric nervous system malignancy. Known mutations accou...
The Hedgehog pathway is a potent regulator of cellular growth and plays a central role in the develo...
Gene mutations impairing the functions of the WNT signaling transduction pathway have been found in ...
The TCF4 gene encodes for the basic helix-loop-helix transcription factor 4 (TCF4), which plays an i...
Suppressor of Fused (SuFu), a tumour suppressor mutated in medulloblastoma, is a central player of H...
The TCF4 gene encodes for the basic helix–loop–helix transcription factor 4 (TCF4), which plays an i...
Current treatment for medulloblastoma is successful in more than half of all cases but results in su...